Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neoplasms Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00521404
What this trial is testing

Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Daiichi Sankyo 65
Testing effectiveness (Phase 2)Looking for participantsNCT03492671
What this trial is testing

Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer

Who this might be right for
Pancreas AdenocarcinomaResectable Pancreatic Cancer
Loma Linda University 30
Large-scale testing (Phase 3)Looking for participantsNCT06598033
What this trial is testing

Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fudan University 50
Large-scale testing (Phase 3)Ended earlyNCT03472833
What this trial is testing

High-dose Vitamin D3 in Pancreas Cancer

Who this might be right for
Pancreas CancerVitamin D DeficiencyQuality of Life
Medical University of Graz 25
Not applicableEnrolling By InvitationNCT06685939
What this trial is testing

The Differences of Complications Between LPD(Laparoscopic Pancreaticoduodenectomy) and OPD(Open Pancreaticoduodenectomy)

Who this might be right for
Pancreatic Neoplasms
Zhijun Bao 220
Testing effectiveness (Phase 2)Looking for participantsNCT07670312
What this trial is testing

Evaluation of XYA02 in Patients With Advanced Solid Tumors

Who this might be right for
MUC1-expressing Advanced, Relapsed and/or Refractory Solid TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more
XYone Therapeutics, Inc 190
Not applicableUnknownNCT05237193
What this trial is testing

A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up

Who this might be right for
Biliary Tract NeoplasmsPancreatic CarcinomaGallbladder Cancer+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 400
Not applicableEnded earlyNCT00541593
What this trial is testing

Natural Orifice Translumenal Endoscopic Surgery (NOTES) Cystgastrostomy for the Treatment of Pancreatic Pseudocysts

Who this might be right for
Pancreatic Pseudocyst
Baystate Medical Center 5
Not applicableLooking for participantsNCT06043921
What this trial is testing

Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel

Who this might be right for
Pancreatic Cancer
Invitae Corporation 150
Not applicableUnknownNCT04245644
What this trial is testing

Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study

Who this might be right for
Disease Free SurvivalOverall SurvivalPancreatic Cancer
Massimo Falconi 800
Very early researchEnded earlyNCT00364364
What this trial is testing

Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Testing effectiveness (Phase 2)UnknownNCT03374293
What this trial is testing

Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Shixiu Wu 21
Testing effectiveness (Phase 2)Study completedNCT01658436
What this trial is testing

BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.

Who this might be right for
Pancreatic Neuroendocrine Tumors (pNET)
Novartis Pharmaceuticals 31
Early research (Phase 1)Ended earlyNCT03122106
What this trial is testing

Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Who this might be right for
Pancreatic CancerPancreas CancerCancer of the Pancreas
Washington University School of Medicine 15
Large-scale testing (Phase 3)Looking for participantsNCT06391892
What this trial is testing

Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery

Who this might be right for
Pancreatic CancerCirculating Tumor CellPredictive Cancer Model
Elisabethinen Hospital 100
Not applicableEnded earlyNCT01103128
What this trial is testing

Validation of a Mouse Model of Pancreatic Carcinogenesis

Who this might be right for
Pancreatic Cancer
Columbia University 450
Not applicableNot Yet RecruitingNCT06787807
What this trial is testing

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Who this might be right for
ObesityColon CancerThyroid Cancer+14 more
Universidade Federal de Pernambuco 103
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Testing effectiveness (Phase 2)UnknownNCT03986294
What this trial is testing

Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 122
Testing effectiveness (Phase 2)Study completedNCT03611556
What this trial is testing

MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.

Who this might be right for
CarcinomaMetastatic Pancreatic Adenocarcinoma
MedImmune LLC 213
Next Page